Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-7 of 7
Keywords: Cost-effectiveness
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Hormone Research in Paediatrics
Horm Res Paediatr (2018) 90 (3): 145–150.
Published Online: 28 September 2018
...David B. Allen Assessing cost-effectiveness of human growth hormone (hGH) treatment to augment height is complicated by uncertainty about how best to measure its therapeutic effect. Cost-conscious growth promotion practice, however, is possible and likely an emerging practical requisite as health...
Journal Articles
Journal:
Hormone Research in Paediatrics
Horm Res Paediatr (2018) 90 (1): 1–7.
Published Online: 26 July 2018
.... Precocious puberty Central precocious puberty Gonadotropin-releasing hormone analogs Hormone therapy Cost-effectiveness Gonadotropin-releasing hormone analogs (GnRHa) are modified preparations of native GnRH designed to increase its potency and half-life and were initially approved...
Journal Articles
Lenneke Schrier, Marieke L. de Kam, Rachel McKinnon, Amalina Che Bakri, Wilma Oostdijk, Theo C.J. Sas, Leonie A. Menke, Barto J. Otten, Sabine M.P.F. de Muinck Keizer-Schrama, Berit Kristrom, Carina Ankarberg-Lindgren, Jacobus Burggraaf, Kerstin Albertsson-Wikland, Jan M. Wit
Journal:
Hormone Research in Paediatrics
Horm Res Paediatr (2014) 81 (5): 319–330.
Published Online: 12 June 2014
...: Growth Hormone (GH) dosage in childhood is adjusted for body size, but there is no consensus whether body weight (BW) or body surface area (BSA) should be used. We aimed at comparing the biological effect and cost-effectiveness of GH treatment dosed per m 2 BSA in comparison with dosing per kg BW...
Journal Articles
Towards Optimal Treatment with Growth Hormone in Short Children and Adolescents: Evidence and Theses
Michael B. Ranke, Anders Lindberg, Primus E. Mullis, Mitchell E. Geffner, Toshi Tanaka, Wayne S. Cutfield, Maïthé Tauber, David Dunger
Journal:
Hormone Research in Paediatrics
Horm Res Paediatr (2013) 79 (2): 51–67.
Published Online: 26 February 2013
..., instructions or products referred to in the content or advertisements. Growth hormone treatment Efficacy Cost-effectiveness Optimization Growth hormone (GH) has a long and complex history [ 1,2 ]. The era of GH treatment started when Raben [ 3 ] proved that replacement with pituitary-derived...
Journal Articles
Subject Area:
Endocrinology
Journal:
Hormone Research in Paediatrics
Hormone Research (1996) 46 (4-5): 222–229.
Published Online: 09 December 2008
... of improvement of respiratory function, morbidity, and quality of life, remain to be shown. Well-designed studies, specifically targeting these end points as well as cost-effectiveness, are needed to better define the place of rhGH in the nutritional support of these patients. 9 12 2008 © 1996 S...
Journal Articles
Journal:
Hormone Research in Paediatrics
Hormone Research (1999) 51 (Suppl. 1): 30–35.
Published Online: 17 November 2004
... as a preferred methodology for analysis in situations of uncertainty, in combination with cost-benefit and cost-effectiveness analyses. Special emphasis is given to quality-of-life considerations in growth hormone (GH) therapy and ways to measure it and express patient preferences. 17 11 2004 1999...
Journal Articles
Journal:
Hormone Research in Paediatrics
Hormone Research (2000) 54 (Suppl. 1): 64–67.
Published Online: 17 November 2004
... that the treatment of these high-risk patients is cost-effective. The rates of morbidity and mortality associated with fractures must also be determined. Several studies show that the probability of disability (inability to climb stairs, walk a mile or perform heavy household chores) after hip fracture is among...